Publication | Closed Access

Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer's disease: Insights from a systems biomedicine perspective

Drug TargetAlzheimer's DiseaseBiomarker TargetDementiaNovel Therapeutic TargetsMolecular BiologyBiomarkersNeurochemical BiomarkersSystems Biomedicine PerspectiveProtein MisfoldingMolecular SignaturesNeurodegenerationSystems BiologyMedicineDrug Discovery